Back
48
Day Range
$109.00
$111.77
52-Week Range
$71.42
$115.33
Volume
155,117
50D / 200D Avg
$94.46
/
$88.84
Prev Close
$109.99
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 43.8 | 0.3 |
| P/B | 6.4 | 3.0 |
| ROE % | 15.8 | 3.7 |
| Net Margin % | 23.1 | 3.8 |
| Rev Growth 5Y % | 12.8 | 10.0 |
| D/E | 0.5 | 0.2 |
Analyst Price Target
Hold
$101.50
-8.6%
Low: $95.00
High: $108.00
Forward P/E
38.48
Forward EPS
$2.89
EPS Growth (est.)
+0.0%
Est. Revenue
278.99M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$0.00
$0.00 – $0.00
|
350.44M | 1 |
| FY2028 |
$3.35
$3.34 – $3.35
|
329.11M | 3 |
| FY2027 |
$3.16
$2.93 – $3.28
|
303.01M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | $0.66 | $0.68 | +2.4% |
| 2025-11-06 | $0.56 | $0.62 | +9.9% |
| 2025-08-05 | $0.57 | $0.60 | +5.3% |
| 2025-05-01 | $0.50 | $0.48 | -4.0% |
| 2025-02-27 | $0.49 | $0.49 | 0.0% |
| 2024-10-31 | $0.44 | $0.49 | +11.4% |
| 2024-08-01 | $0.47 | $0.52 | +10.6% |
| 2024-05-02 | $0.39 | $0.44 | +12.8% |
Dividend History
7 yr streakYield
0.01%
Payout Ratio
0.31%
Growth (3Y)
16.96%
Growth (5Y)
16.05%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 12, 2026 | Mar 26, 2026 | $0.25 | 0.80% |
| Nov 20, 2025 | Dec 04, 2025 | $0.20 | 0.95% |
| Aug 21, 2025 | Sep 04, 2025 | $0.20 | 0.79% |
| May 15, 2025 | May 29, 2025 | $0.20 | 0.86% |
| Mar 13, 2025 | Mar 27, 2025 | $0.20 | 0.86% |
| Nov 21, 2024 | Dec 05, 2024 | $0.16 | 0.60% |
| Aug 15, 2024 | Aug 29, 2024 | $0.16 | 0.74% |
| May 15, 2024 | May 30, 2024 | $0.16 | 0.77% |
| Mar 13, 2024 | Mar 28, 2024 | $0.16 | 0.87% |
| Nov 15, 2023 | Nov 30, 2023 | $0.14 | 1.07% |
| Aug 16, 2023 | Aug 31, 2023 | $0.14 | 0.98% |
| May 16, 2023 | Jun 01, 2023 | $0.14 | 0.82% |
| Mar 08, 2023 | Mar 23, 2023 | $0.14 | 1.05% |
| Nov 16, 2022 | Dec 01, 2022 | $0.13 | 1.10% |
| Aug 24, 2022 | Sep 08, 2022 | $0.13 | 0.96% |
| May 16, 2022 | Jun 02, 2022 | $0.13 | 1.08% |
| Mar 07, 2022 | Mar 24, 2022 | $0.13 | 0.98% |
| Nov 18, 2021 | Dec 02, 2021 | $0.11 | 0.85% |
| Aug 25, 2021 | Sep 09, 2021 | $0.11 | 0.78% |
| May 18, 2021 | Jun 03, 2021 | $0.11 | 0.85% |
Key Takeaways
Revenue grew 12.75% annually over 5 years — strong growth
Earnings grew 31.10% over the past year
ROE of 15.80% — decent returns on equity
Net margin of 23.13% shows strong profitability
Debt/Equity of 0.47 — conservative balance sheet
Generating 74.47M in free cash flow
Growth
Revenue Growth (5Y)
12.75%
Revenue (1Y)13.53%
Earnings (1Y)31.10%
FCF Growth (3Y)58.92%
Quality
Return on Equity
15.80%
ROIC8.80%
Net Margin23.13%
Op. Margin27.21%
Safety
Debt / Equity
0.47
Current Ratio12.89
Interest Coverage13.10
Valuation
P/E Ratio
43.83
Forward P/E37.36
P/B Ratio6.43
EV/EBITDA39.57
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.53% | Revenue Growth (3Y) | 13.58% |
| Earnings Growth (1Y) | 31.10% | Earnings Growth (3Y) | 38.48% |
| Revenue Growth (5Y) | 12.75% | Earnings Growth (5Y) | 21.03% |
| Profitability | |||
| Revenue (TTM) | 249.60M | Net Income (TTM) | 57.73M |
| ROE | 15.80% | ROA | 9.38% |
| Gross Margin | 71.53% | Operating Margin | 27.21% |
| Net Margin | 23.13% | Free Cash Flow (TTM) | 74.47M |
| ROIC | 8.80% | FCF Growth (3Y) | 58.92% |
| Safety | |||
| Debt / Equity | 0.47 | Current Ratio | 12.89 |
| Interest Coverage | 13.10 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.31% |
| Dividend Growth (3Y) | 16.96% | Dividend Growth (5Y) | 16.05% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 43.83 | Forward P/E | 37.36 |
| P/B Ratio | 6.43 | P/S Ratio | 10.14 |
| PEG Ratio | 1.06 | Forward PEG | N/A |
| EV/EBITDA | 39.57 | Fwd EV/EBITDA | 33.29 |
| Forward P/S | 9.07 | Fwd Earnings Yield | 2.68% |
| FCF Yield | 2.94% | ||
| Market Cap | 2.53B | Enterprise Value | 2.69B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 249.60M | 219.86M | 193.48M | 161.65M | 154.42M |
| Net Income | 57.73M | 44.04M | 30.11M | 20.64M | 26.91M |
| EPS (Diluted) | 2.52 | 1.93 | 1.34 | 0.93 | 1.25 |
| Gross Profit | 178.54M | 150.90M | 127.05M | 104.90M | 101.38M |
| Operating Income | 67.91M | 52.26M | 36.71M | 26.83M | 36.43M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 615.69M | 551.82M | 346.78M | 310.48M | 292.80M |
| Total Liabilities | 222.17M | 214.53M | 48.88M | 42.28M | 38.65M |
| Shareholders' Equity | 393.52M | 337.29M | 297.90M | 268.20M | 254.15M |
| Total Debt | 185.59M | 185.69M | 19.10M | 16.60M | 15.94M |
| Cash & Equivalents | 28.24M | 25.61M | 24.27M | 19.13M | 13.86M |
| Current Assets | 468.23M | 402.19M | 194.60M | 161.73M | 139.88M |
| Current Liabilities | 36.32M | 30.61M | 29.88M | 25.33M | 21.81M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Balanced Risk
#63 of 151
Recent Activity
Exited
Cash Flow Compounder
Mar 25, 2026
Entered
Cash Flow Compounder
Mar 24, 2026
Entered
Balanced Risk
Mar 24, 2026